Nihon Kohden (OTCMKTS:NHNKY) Hits New 52-Week Low – Time to Sell?

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $8.87 and last traded at $9.41, with a volume of 8254 shares. The stock had previously closed at $9.04.

Analyst Upgrades and Downgrades

NHNKY has been the topic of a number of analyst reports. Zacks Research raised Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. UBS Group raised Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Nihon Kohden Trading Down 1.7%

The company has a market cap of $1.52 billion, a PE ratio of 17.43 and a beta of 0.41. The firm’s 50-day simple moving average is $9.48 and its two-hundred day simple moving average is $10.55.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%. As a group, analysts predict that Nihon Kohden Corporation will post 0.48 EPS for the current year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.